Cerca
Items 1-1 di 1
Egfr inhibition in a pretreated sacral chordoma: a rolefor erlotinib? Case report and a brief review of literature
(2017)
We describe the case of a 69-year old
male with an EGFR- positive Imatinib refractory
sacral chordoma with synchronous lung metastases,
treated with erlotinib, a first- generation EGFR
inhibitor. After disease progression ...